Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study. Song Z, Li Z, Zhang Y, Wang P, et al. Eur J Cancer 2025;232:116153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Song Z, Li Z, Zhang Y, Wang P, et al. Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study. Eur J Cancer 2025;232:116153.
PMID: 41330054